Users Coming Off Anti-Obesity Jabs Regain Pounds Far More Rapidly Than Dieters
New research indicates that people who stop using new weight-loss injections like Mounjaro or Wegovy may regain lost weight far faster than those who halt traditional lifestyle programs.
Research printed in a prominent health publication demonstrates that while obese people frequently drop about a fifth of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month after stopping.
"Individuals purchasing such medications need to be cognizant of the danger of fast weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to starting mass in about a year and a half.
Comparing Therapies
The study, which looked at 37 of trials involving over 9,000 of patients, compared the effects of the injectable medications with other pills.
Researchers point out that people who shed pounds through lifestyle changes alone typically see a slower weight regain—perhaps 0.1 kg a month—after stopping.
The Reason for the Rapid Rebound
Nutrition scientists believe the way of the drugs accounts for the amplified rebound.
These medications mimic a natural hormone called GLP-1, which moderates appetite.
"Artificially providing the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making overeating a significant risk."
A Chronic Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the therapy should be considered ongoing.
This perspective is echoed by drug manufacturers, who state that the results "underscore the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Accounts
People who have discontinued the medication describe a intense resurgence of hunger.
"I experienced a trigger flipping and I was suddenly extremely hungry," described a patient.
The struggle is compounded if users have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Interest
Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is greater among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on combined behavioural support.